Academic literature on the topic 'Nootropics'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Nootropics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Nootropics"

1

Suliman, Noor Azuin, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, and Rusliza Basir. "Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/4391375.

Full text
Abstract:
Nootropics or smart drugs are well-known compounds or supplements that enhance the cognitive performance. They work by increasing the mental function such as memory, creativity, motivation, and attention. Recent researches were focused on establishing a new potential nootropic derived from synthetic and natural products. The influence of nootropic in the brain has been studied widely. The nootropic affects the brain performances through number of mechanisms or pathways, for example, dopaminergic pathway. Previous researches have reported the influence of nootropics on treating memory disorders
APA, Harvard, Vancouver, ISO, and other styles
2

Malík, Matěj, and Pavel Tlustoš. "Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs." Nutrients 14, no. 16 (2022): 3367. http://dx.doi.org/10.3390/nu14163367.

Full text
Abstract:
Nootropics, also known as “smart drugs” are a diverse group of medicinal substances whose action improves human thinking, learning, and memory, especially in cases where these functions are impaired. This review provides an up-to-date overview of the potential effectiveness and importance of nootropics. Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic compounds, substances increasing brain metabolism, cholinergic, and plants and their extracts with nootropic effects. Each subgroup of nootropics contains several
APA, Harvard, Vancouver, ISO, and other styles
3

Vitthalrao, Leena Sakhare. "NOOTROPICS AGENTS: PHARMACEUTICAL ASPECT, COMMON EXAMPLES AND THEIR APPLICATIONS." Journal of Drug Delivery and Therapeutics 8, no. 5-s (2018): 59–61. http://dx.doi.org/10.22270/jddt.v8i5-s.1940.

Full text
Abstract:
Nootropics compounds are one of the important categories of medicinal agents act as cognitive enhancers and neuroprotective. These agents mainly used to improve memory related functioning of brain. Nootropic compounds exhibited various neural activities and boost functioning of central nervous system including improvement of intellectual, memory and learning capacity. These agents also offer significant relief in various neurodegenerative disorders such as parkinson disease and alzheimer disease. Drugs, nutraceuticals, supplements and functional foods may be used as nootropics agents to enhanc
APA, Harvard, Vancouver, ISO, and other styles
4

Patel, Jenilkumar, Angelle King, Mahant Malempati, and Milee Patel. "Understanding nootropics and cognitive enhancement: mechanism of action and ethical considerations." Health Open Research 6 (January 9, 2024): 2. http://dx.doi.org/10.12688/healthopenres.13504.1.

Full text
Abstract:
Nootropics are substances that enhance cognition through various mechanisms. Nootropics include various substances, ranging from derivatives of neurotransmitters to naturally occurring plants. They are used therapeutically for certain psychological disorders including Alzheimer’s dementia and mild cognitive impairment. More recently, healthy individuals have been shown to consume nootropics to enhance mental processes above baseline levels. Nootropic modes of action vary, but the most supported mechanisms include increased acetylcholine levels in synapses, increased levels of monoamine oxidase
APA, Harvard, Vancouver, ISO, and other styles
5

Shabanov, P. D. "The Origins and Background of the Creation of the Nootropics Concept." Нейрохимия 40, no. 2 (2023): 101–7. http://dx.doi.org/10.31857/s1027813323020127.

Full text
Abstract:
The concept of nootropics was introduced into pharmacology in the early 1970s by Corneliu Giurgea, a Belgian pharmacologist of Romanian origin, based on the study of 2-oxo-1-pyrrolidine derivatives, which later became known as racetams. The paper substantiates the position that the emergence of modern ideas about nootropics and similar compounds (psychoenergizers, antihypoxants, actoprotectors) in a certain sense was preceded by the concept of adaptogens by N.V. Lazarev (1953–1958), whose theoretical development went towards concretization of certain provisions of this concept. The formation o
APA, Harvard, Vancouver, ISO, and other styles
6

Varshney, PAYAK, RAKESH SHARMA, RAM GARG, and MAMTA SHARMA. "A Review on Natural Nootropic Medicines and Their Potential Human Health Benefits." Indian Journal of Health Care, Medical & Pharmacy Practice 4, no. 2 (2023): 36–45. http://dx.doi.org/10.59551/ijhmp/25832069/2023.4.2.40.

Full text
Abstract:
Nootropics, often known as smart agents or supplements that improve cognitive ability. They operate by improving cognitive abilities such as memory, creativity, motivation, and concentration. Recent studies have focused on a natural nootropics. The effects of nootropics on the brain have been extensively researched. These influences brain functioning via a variety of methods or routes, such as the dopaminergic system. Previous studies have found that nootropics can help treat memory illnesses like Alzheimer's, Parkinson's, and Huntington’s. These illnesses have been shown to disrupt the same n
APA, Harvard, Vancouver, ISO, and other styles
7

Chiroma, Samaila Musa, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohamad Taufik Hidayat Baharuldin, Zulkhairi Amom, and Saravanan Jagadeesan. "The use of nootropics in Alzheimer’s disease: is there light at the end of the tunnel?" Biomedical Research and Therapy 6, no. 1 (2019): 2937–44. http://dx.doi.org/10.15419/bmrat.v6i1.513.

Full text
Abstract:
Background: The nootropic or simply known as smart drug is a common term given to any compound that is responsible for enhancing mental capability or performance. Alzheimer's disease is characterized clinically by lose of cognitive abilities and pathologically by two hallmark lesions, neurofibrillary tangles and senile plaques. It is unfortunate that AD has no cure yet. In this review attempt has been made to elucidate the general views on AD pathogenic hypotheses and common nootropics being used in AD research.
 Methods: Articles from credible scientific data bases such as Sciencdirect,
APA, Harvard, Vancouver, ISO, and other styles
8

Sydorenko, A. H. "NOOTROPICS: A LONG WAY IN HALF A CENTURY." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 23, no. 1 (2023): 199–204. http://dx.doi.org/10.31718/2077-1096.23.1.199.

Full text
Abstract:
Introduction. Currently, there are drugs that can improve cognitive processes. They are nootropics. The term "nootropics" was introduced in 1972, when piracetam's memory-enhancing properties were discovered, and this group of drugs has served the human benefit for half a century. The purpose of the work is to analyze known facts and new trends in the development of nootropics as a pharmacological group. Materials and methods. Internet resources (PubMed, Google Scholar, CrossRef) are used to search for information. Original research articles, meta-analyses and systematic reviews are included in
APA, Harvard, Vancouver, ISO, and other styles
9

Rudra, Pranab. "Ethical Underpinning and Implications of “Nootropic” Concept." Acta Universitatis Lodziensis. Folia Philosophica. Ethica-Aesthetica-Practica, no. 32 (December 30, 2018): 31–45. http://dx.doi.org/10.18778/0208-6107.32.03.

Full text
Abstract:
The current generation paving the path for new research marks a milestone to attain the ancient goal of improving our cognition. To date, increased prevalence of cognitive enhancers by healthy people has raised the scientific community’s attention as well as media coverage. In particular, nootropics such as piracetam promise to offer modest improvements in cognitive performance. The long-lasting impetus of this “holistic enhancer” convinced scientists as well as ethicists to discuss its potential ethical implications and future directions. Moreover, there are discrepancies in the concept of a
APA, Harvard, Vancouver, ISO, and other styles
10

Onaolapo, Adejoke Yetunde, Adebimpe Yemisi Obelawo, and Olakunle James Onaolapo. "Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline." Current Aging Science 12, no. 1 (2019): 2–14. http://dx.doi.org/10.2174/1874609812666190311160754.

Full text
Abstract:
Background: Age-related cognitive decline has been suggested to result from an increase in the brain neuron loss, which is attributable to continued derangement of the brain’s oxidant/ antioxidant balance. Increased oxidative stress and a concomitant decrease in the brain’s antioxidant defense system have been associated with functional senescence and organismal ageing. However, nature has configured certain foods to be rich sources of nootropic agents, with research showing that increased consumption of such foods or food ingredients may be protective against ageing-related memory decline. Th
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Nootropics"

1

Sanku, Rajesh Kishore kumar. "DEVELOPMENT AND BIOLOGICAL EVALUATION OF CARBONIC ANHYDRASE MODULATORS AS POTENTIAL NOOTROPICS AND ANTICANCER AGENTS." Diss., Temple University Libraries, 2018. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/487142.

Full text
Abstract:
Pharmaceutical Sciences<br>Ph.D.<br>Cancer is the second most common cause of death in the world. One of the objectives of this thesis is to biologically evaluate a series of anti-cancer polymeric aromatic/heterocyclic bis-sulfonamides and pyridinium sulfonamides which were synthesized from three established aminosulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor pharmacophores. Testing of these novel inhibitors and their precursors against a panel of membrane-bound CA isoforms, including tumor-overexpressed CA IX and XII and cytosolic isozymes, identified nanomolar-potent inhibitors ag
APA, Harvard, Vancouver, ISO, and other styles
2

Prevost, Dominique. "Le Piracetam, chef de file des nootropes." Bordeaux 2, 1991. http://www.theses.fr/1991BOR2P065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

MONTAVONT, DIDIER VERONIQUE. "Recherches recentes dans le domaine des nootropes." Strasbourg 1, 1993. http://www.theses.fr/1993STR15031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mohamed, Ahmed Dahir. "The neuroscience & ethics of cognitive enhancement in healthy individuals." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607755.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McCormick, Sean Eli. "Transcendence: An Ethical Analysis of Enhancement Technologies." Cleveland State University / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=csu1464233924.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barnes, J. M. "Neurochemical assessments of the actions of novel agents having nootropic and anxiolytic potential." Thesis, University of Bradford, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.234701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nanas, Nikolaos. "Towards Nootropia : a non-linear approach to adaptive document filtering." Thesis, Open University, 2003. http://oro.open.ac.uk/54624/.

Full text
Abstract:
In recent years, it has become increasingly difficult for users to find relevant information within the accessible glut. Research in Information Filtering (IF) tackles this problem through a tailored representation of the user interests, a user profile. Traditionally, IF inherits techniques from the related and more well established domains of Information Retrieval and Text Categorisation. These include, linear profile representations that exclude term dependencies and may only effectively represent a single topic of interest, and linear learning algorithms that achieve a steady profile adapta
APA, Harvard, Vancouver, ISO, and other styles
8

RATTO, DANIELA. "Nootropic and antioxidant metabolites of Hericium erinaceus enhanced healthy aging in a preclinical model and improved mood disorders in patients." Doctoral thesis, Università degli studi di Pavia, 2022. http://hdl.handle.net/11571/1452903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hamilton, Mindy. "A Critical Discourse Analysis of Cognitive Enhancement Advertising: The Contemporary Mind as a Commodity." University of Cincinnati / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1535468783036117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tedelind, Jonas. "Nootropikum : Piracetam som kognitionsförbättrare." Thesis, Umeå universitet, Farmakologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-137152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Nootropics"

1

Asdrachas, Spyros I. Oikonomia kai nootropies. Hermēs, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Polkovnikova, Yuliya. Liposomal forms of nootropic drugs. INFRA-M Academic Publishing LLC., 2023. http://dx.doi.org/10.12737/1959243.

Full text
Abstract:
The monograph summarizes the results of our own research in comparison with the literature data on the development of the composition and technology of liposomal dosage forms of nootropic action.&#x0D; It is intended for researchers in the field of pharmacy, biology and medicine, as well as for pharmacists, teachers, graduate students, residents and students engaged in scientific research.
APA, Harvard, Vancouver, ISO, and other styles
3

Liapēs, Vangelēs Pan. Arvanitika zakonia: Nootropia. Ekdoseis "Dōdōnē", 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nootropika-Symposium (3rd 1986 Dresden, Germany). Nootropika: Beiträge des 3. Nootropika-Symposiums in Dresden, 3.-5. März 1986. bei der Carus-Akademie, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Helmchen, Hanfried, ed. Wirkungen und Wirksamkeit von Nootropika. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73811-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Skoulidas, Ēlias. Hellada kai Alvania ston psychro polemo: Politikes, ideologies, nootropies. Alexandreia, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Heidrich, Heinz, ed. Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70786-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ley, Beth M. Marvelous memory boosters: Recharge your brain with special nutrients proven to boost your brain power! BL Publications, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hutchison, Michael. Mega brain power: Transform your life with mind machines and brain nutrients. Hyperion, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hutchison, Michael. Megabrain power: Transform your life with mind machines and brain nutrients. Hyperion, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Nootropics"

1

Andrews, Anne M., Greg A. Gerhardt, Lynette C. Daws, et al. "Nootropics." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_964.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Conners, C. Keith, and Elizabeth P. Sparrow. "Nootropics And Foods." In Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4899-0086-9_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Keith Conners, C. "Nootropics and Foods." In Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2884-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Maan, Preeti, Nisha Gupta, and Shilpi Chauhan. "Nootropics: Traditional Medicinal Prospective." In Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer’s Disease. Apple Academic Press, 2025. https://doi.org/10.1201/9781003570356-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wojszel, Zyta Beata. "Nootropics (Piracetam, Pyritinol, Co-dergocrine, Meclophenoxat, Pentoxifylline, Nimodipine)." In NeuroPsychopharmacotherapy. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-62059-2_419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Brzozowski, Fabíola Stolf, and Marcia da Silva Mazon. "Nootropics in the Era of Affective Capitalism: Drug Consumption and Discourse Effects." In The International Library of Bioethics. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-22891-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rommelspacher, H. "Nootropika." In Pharmakologie und Toxikologie. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-662-00487-6_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rommelspacher, H. "Nootropika." In Pharmakologie und Toxikologie. Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-98030-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Benkert, Otto, Hanns Hippius, and Hermann Wetzel. "Nootropika." In Psychiatrische Pharmakotherapie. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-662-00715-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brosch, Werner. "Nootropika." In Wörterbuch der Psychotherapie. Springer Vienna, 2000. http://dx.doi.org/10.1007/978-3-211-99131-2_1251.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Nootropics"

1

Levi, Russell, Saad Ahmed, and Zachary Harris. "Can Nutritional Supplements Benefit Patients Receiving Treatment for Neurodegenerative Disorders?" In 28th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2024. http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.53_2024.

Full text
Abstract:
As the prevalence of neurocognitive disorders rises globally, developing new methodologies of prevention and treatment is crucial. This literature review examines the efficacy of adding nutritional supplements, specifically nootropics, with traditional pharmacological regimens on various neurocognitive and neurodegenerative disorders. Primary, peer-reviewed research, including both human and animal studies, was assesed to determine if there was a benefifical, minimal, or detrimental effect on symptom progression. The inclusion criteria focused on studies that evaluated the reduction in disease
APA, Harvard, Vancouver, ISO, and other styles
2

Moriau, M., E. Lavenne-Pardonge, and C. H. Col-De Beys. "TREATMENT OF RAYNAUD SYNDROMES WITH PIRACETAM(NOOTROPIL R),NOOTROPIC AND ANIPLATELET AGENT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643426.

Full text
Abstract:
Three prospective studies have been performed with piracetam (Nootropil ®-) in the treatment of Raynaud disease and syndromes.The first one, realized in 20 cases of Raynaud disease established that 8 g piracetam daily was the optimal dosage necessary to obtain a significant clinical, ultrasonic and biologic improvement.In the second one, 58 cases of Raynaud syndromes (47 idiopathic and 11 associated with systemic disease) were treated with 8 g daily piracetam during 6 to 12 months. A clinical and ultrasonic improvement was observed in 75 and 80 % of the cases and a normalisation of the disturb
APA, Harvard, Vancouver, ISO, and other styles
3

Сметана, Владимир Васильевич. "CONTEMPORARY APPROACHES TO COGNITIVE ENHANCEMENT: A PHILOSOPHICAL ANALYSIS." In Перспективные исследования в сфере образования, культуры и общества: сборник статей международной научной конференции (Санкт-Петербург, Март 2025). Crossref, 2025. https://doi.org/10.58351/250313.2025.16.26.006.

Full text
Abstract:
Данная статья посвящена философскому анализу современных подходов к улучшению когнитивных функций человека. В работе рассматриваются два основных направления: фармакологическое улучшение (ноотропы и стимуляторы) и технологическое улучшение (когнитивная тренировка и интерфейсы «мозг-компьютер»). Цель статьи - не только описать существующие методы и технологии, но и выявить их философские основания, этические дилеммы, антропологические и социальные риски, а также возможные перспективы и ограничения. В статье обобщаются основные выводы, формулируются открытые вопросы и перспективы дальнейших иссл
APA, Harvard, Vancouver, ISO, and other styles
4

"Nootropic activity of humic substances." In Seventh International Conference on Humic Innovative Technologies "Humic substances and technologies for resilience" (HIT – 2022). NP CBR "Humus Sapiens", 2022. http://dx.doi.org/10.36291/hit.2022.065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Маркова, К. В., Я. Г. Разуваева, and Д. Н. Оленников. "STUDY OF THE NOOTROPIC EFFECTS OF ECDYSTEROIDCONTAINING MEDICINES IN SCOPOLAMINE AMNESIA." In ОТ БИОХИМИИ РАСТЕНИЙ К БИОХИМИИ ЧЕЛОВЕКА. Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений", 2022. http://dx.doi.org/10.52101/9785870191041_381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sheptytsky, Vladimir, Anastasia Garbuzneac, Oliga Mangul, Iulia Bereziuc, Anastasia Vasilciuc, and Svetlana Burtseva. "NEUROPROTECTIVE AND NOOTROPIC EFFECTS OF THE PRODUCTS OF VITAL ACTIVITY OF STREPTOMYCES." In XVIII INTERNATIONAL INTERDISCIPLINARY CONGRESS NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY. LCC MAKS Press, 2022. http://dx.doi.org/10.29003/m2998.sudak.ns2022-18/387-388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Garbuzneac, Anastasia, Vladimir Septitchi та Svetlana Burteva. "Пространственное обучение и память белых крыс в водном лабиринте морриса под влиянием биомассы штаммов стрептомицетов, выделенных из почв Республики Молдова". У "Fiziologia şi sănătatea", congresul fiziologilor. Bulletin of the Academy of Sciences of Moldova. Medical Sciences, 2025. https://doi.org/10.52692/cfzl2024.23.

Full text
Abstract:
The aim of the work is to investigate the effect of long-term consumption of biomass of local strains of streptomycetes - Streptomyces massasporeus CNMN-Ac-06 and Streptomyces fradiae CNMN-Ac-11 on the spatial learning and memory in rats in the Morris water maze. It was found that biomass of strains Streptomyces massasporeus CNMN-Ac-06 and, to a greater extent, Streptomyces fradiae CNMN-Ac-11 leads to a noticeable decrease in such indicators, recorded during the training of animals in the Morris water maze, as the duration of the latent period of the animals the platform, the length of the pat
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!